Skip to main content
Top
Published in: Inflammation 3/2018

Open Access 01-06-2018 | ORIGINAL ARTICLE

Serum from the Human Fracture Hematoma Contains a Potent Inducer of Neutrophil Chemotaxis

Authors: Okan W. Bastian, Mikolaj H. Mrozek, Marco Raaben, Luke P. H. Leenen, Leo Koenderman, Taco J. Blokhuis

Published in: Inflammation | Issue 3/2018

Login to get access

Abstract

A controlled local inflammatory response is essential for adequate fracture healing. However, the current literature suggests that local and systemic hyper-inflammatory conditions after major trauma induce increased influx of neutrophils into the fracture hematoma (FH) and impair bone regeneration. Inhibiting neutrophil chemotaxis towards the FH without compromising the hosts’ defense may therefore be a target of future therapies that prevent impairment of fracture healing after major trauma. We investigated whether chemotaxis of neutrophils towards the FH could be studied in vitro. Moreover, we determined whether chemotaxis of neutrophils towards the FH was mediated by the CXCR1, CXCR2, FPR, and C5aR receptors. Human FHs were isolated during an open reduction internal fixation (ORIF) procedure within 3 days after trauma and spun down to obtain the fracture hematoma serum. Neutrophil migration towards the FH was studied using Ibidi™ Chemotaxis3D μ-Slides and image analysis of individual neutrophil tracks was performed. Our study showed that the human FH induces significant neutrophil chemotaxis, which was not affected by blocking CXCR1 and CXCR2. In contrast, neutrophil chemotaxis towards the FH was significantly inhibited by chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS), which blocks FPR and C5aR. Blocking only C5aR with CHIPSΔ1F also significantly inhibited neutrophil chemotaxis towards the FH. Our finding that neutrophil chemotaxis towards the human FH can be blocked in vitro using CHIPS may aid the development of therapies that prevent impairment of fracture healing after major trauma.
Literature
1.
go back to reference Bastian, Okan, Janesh Pillay, Jacqueline Alblas, Luke Leenen, Leo Koenderman, and Taco Blokhuis. 2011. Systemic inflammation and fracture healing. Journal of Leukocyte Biology 89: 669–673.CrossRefPubMed Bastian, Okan, Janesh Pillay, Jacqueline Alblas, Luke Leenen, Leo Koenderman, and Taco Blokhuis. 2011. Systemic inflammation and fracture healing. Journal of Leukocyte Biology 89: 669–673.CrossRefPubMed
2.
go back to reference Giannoudis, Peter V., Thomas A. Einhorn, and David Marsh. 2007. Fracture healing: the diamond concept. Injury 38 (Suppl 4): S3–S6.CrossRefPubMed Giannoudis, Peter V., Thomas A. Einhorn, and David Marsh. 2007. Fracture healing: the diamond concept. Injury 38 (Suppl 4): S3–S6.CrossRefPubMed
3.
go back to reference Mizuno, K., K. Mineo, T. Tachibana, M. Sumi, T. Matsubara, and K. Hirohata. 1990. The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma. Journal of Bone and Joint Surgery-British 72 (JBJS (Br)): 822.CrossRef Mizuno, K., K. Mineo, T. Tachibana, M. Sumi, T. Matsubara, and K. Hirohata. 1990. The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma. Journal of Bone and Joint Surgery-British 72 (JBJS (Br)): 822.CrossRef
4.
go back to reference Street, J, D Winter, J H Wang, A Wakai, A McGuinness, and H P Redmond. 2000. Is human fracture hematoma inherently angiogenic? Clin Orthop.Relat Res. Department of Academic Surgery, Cork University Hospital, Ireland: 224–237. Street, J, D Winter, J H Wang, A Wakai, A McGuinness, and H P Redmond. 2000. Is human fracture hematoma inherently angiogenic? Clin Orthop.Relat Res. Department of Academic Surgery, Cork University Hospital, Ireland: 224–237.
5.
go back to reference Grundnes, O, and O Reikeras. 1993. The importance of the hematoma for fracture healing in rats. Acta Orthop.Scand 64. Department of Orthopedics, University Hospital, Tromso, Norway: 340–342. Grundnes, O, and O Reikeras. 1993. The importance of the hematoma for fracture healing in rats. Acta Orthop.Scand 64. Department of Orthopedics, University Hospital, Tromso, Norway: 340–342.
6.
go back to reference Park, Sang-Hyun, Mauricio Silva, Won-Jong Bahk, Harry McKellop, and Jay R. Lieberman. 2002. Effect of repeated irrigation and debridement on fracture healing in an animal model. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society 20: 1197–1204. https://doi.org/10.1016/S0736-0266(02)00072-4.CrossRef Park, Sang-Hyun, Mauricio Silva, Won-Jong Bahk, Harry McKellop, and Jay R. Lieberman. 2002. Effect of repeated irrigation and debridement on fracture healing in an animal model. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society 20: 1197–1204. https://​doi.​org/​10.​1016/​S0736-0266(02)00072-4.CrossRef
8.
go back to reference Grundnes, O, and O Reikeraas 2000. Effects of macrophage activation on bone healing. J Orthop.Sci 5. Departments of Orthopedics, Institute of Clinical Medicine, University of Tromso and National Hospital, University of Oslo, Norway: 243–247. Grundnes, O, and O Reikeraas 2000. Effects of macrophage activation on bone healing. J Orthop.Sci 5. Departments of Orthopedics, Institute of Clinical Medicine, University of Tromso and National Hospital, University of Oslo, Norway: 243–247.
10.
go back to reference Recknagel, Stefan, Ronny Bindl, Julian Kurz, Tim Wehner, Christian Ehrnthaller, Markus Werner Knöferl, Florian Gebhard, Markus Huber-Lang, Lutz Claes, and Anita Ignatius. 2011. Experimental blunt chest trauma impairs fracture healing in rats. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society 29: 734–739.CrossRef Recknagel, Stefan, Ronny Bindl, Julian Kurz, Tim Wehner, Christian Ehrnthaller, Markus Werner Knöferl, Florian Gebhard, Markus Huber-Lang, Lutz Claes, and Anita Ignatius. 2011. Experimental blunt chest trauma impairs fracture healing in rats. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society 29: 734–739.CrossRef
12.
go back to reference Karladani, A H, H Granhed, J Kärrholm, J Styf, and J Karrholm. 2001. The influence of fracture etiology and type on fracture healing: a review of 104 consecutive tibial shaft fractures. Arch Orthop.Trauma Surg 121. Department of Orthopedics Surgery, Sahlgrenska University Hospital, Goteborg University, Sweden. abbas.karladani@orthop.gu.se: 325–328. Karladani, A H, H Granhed, J Kärrholm, J Styf, and J Karrholm. 2001. The influence of fracture etiology and type on fracture healing: a review of 104 consecutive tibial shaft fractures. Arch Orthop.Trauma Surg 121. Department of Orthopedics Surgery, Sahlgrenska University Hospital, Goteborg University, Sweden. abbas.karladani@orthop.gu.se: 325–328.
13.
go back to reference Kanakaris, N.K., and Peter V. Giannoudis. 2007. The health economics of the treatment of long-bone non-unions. Injury 38 (Elsevier): S77–S84.CrossRefPubMed Kanakaris, N.K., and Peter V. Giannoudis. 2007. The health economics of the treatment of long-bone non-unions. Injury 38 (Elsevier): S77–S84.CrossRefPubMed
14.
go back to reference Recknagel, Stefan, Ronny Bindl, Christoph Brochhausen, Melanie Göckelmann, Tim Wehner, Philipp Schoengraf, Markus Huber-Lang, Lutz Claes, and Anita Ignatius. 2013. Systemic inflammation induced by a thoracic trauma alters the cellular composition of the early fracture callus. The Journal of Trauma and Acute Care Surgery 74: 531–537. https://doi.org/10.1097/TA.0b013e318278956d. Recknagel, Stefan, Ronny Bindl, Christoph Brochhausen, Melanie Göckelmann, Tim Wehner, Philipp Schoengraf, Markus Huber-Lang, Lutz Claes, and Anita Ignatius. 2013. Systemic inflammation induced by a thoracic trauma alters the cellular composition of the early fracture callus. The Journal of Trauma and Acute Care Surgery 74: 531–537. https://​doi.​org/​10.​1097/​TA.​0b013e318278956d​.
15.
go back to reference Recknagel, Stefan, Ronny Bindl, Julian Kurz, Tim Wehner, Philipp Schoengraf, Christian Ehrnthaller, Qu Hongchang, et al. 2012. C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healing. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 30: 581–586. https://doi.org/10.1002/jor.21561.CrossRef Recknagel, Stefan, Ronny Bindl, Julian Kurz, Tim Wehner, Philipp Schoengraf, Christian Ehrnthaller, Qu Hongchang, et al. 2012. C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healing. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 30: 581–586. https://​doi.​org/​10.​1002/​jor.​21561.CrossRef
16.
go back to reference Grogaard, B, B Gerdin, and O Reikeras. 1990. The polymorphonuclear leukocyte: has it a role in fracture healing? Arch Orthop.Trauma Surg 109. Department of Surgery, Ulleval University Hospital, Oslo, Norway: 268–271. Grogaard, B, B Gerdin, and O Reikeras. 1990. The polymorphonuclear leukocyte: has it a role in fracture healing? Arch Orthop.Trauma Surg 109. Department of Surgery, Ulleval University Hospital, Oslo, Norway: 268–271.
18.
go back to reference Koenderman, Leo, Jan A.M. Van Der Linden, Henk Honing, and Laurien H. Ulfman. 2010. Integrins on neutrophils are dispensable for migration into three-dimensional fibrin gels. Thrombosis and Haemostasis 104: 599–608.CrossRefPubMed Koenderman, Leo, Jan A.M. Van Der Linden, Henk Honing, and Laurien H. Ulfman. 2010. Integrins on neutrophils are dispensable for migration into three-dimensional fibrin gels. Thrombosis and Haemostasis 104: 599–608.CrossRefPubMed
20.
go back to reference Wolf, M, M B Delgado, S A Jones, B Dewald, I Clark-Lewis, and M Baggiolini. 1998. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. European Journal of Immunology 28: 164–70. doi: https://doi.org/10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S. Wolf, M, M B Delgado, S A Jones, B Dewald, I Clark-Lewis, and M Baggiolini. 1998. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. European Journal of Immunology 28: 164–70. doi: https://​doi.​org/​10.​1002/​(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S.
22.
go back to reference de Haas, Carla J C, Karin Ellen Veldkamp, Andreas Peschel, Floor Weerkamp, Willem J B Van Wamel, Erik C J M Heezius, Miriam J J G Poppelier, Kok P M Van Kessel, and Jos A G van Strijp. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. The Journal of experimental medicine 199. The Rockefeller University Press: 687–95. https://doi.org/10.1084/jem.20031636. de Haas, Carla J C, Karin Ellen Veldkamp, Andreas Peschel, Floor Weerkamp, Willem J B Van Wamel, Erik C J M Heezius, Miriam J J G Poppelier, Kok P M Van Kessel, and Jos A G van Strijp. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. The Journal of experimental medicine 199. The Rockefeller University Press: 687–95. https://​doi.​org/​10.​1084/​jem.​20031636.
23.
go back to reference Postma, Bent, Miriam J. Poppelier, Joost C. van Galen, Eric R. Prossnitz, Jos A.G. van Strijp, Carla J.C. de Haas, and Kok P.M. van Kessel. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. Journal of immunology (Baltimore, Md. : 1950) 172: 6994–7001.CrossRef Postma, Bent, Miriam J. Poppelier, Joost C. van Galen, Eric R. Prossnitz, Jos A.G. van Strijp, Carla J.C. de Haas, and Kok P.M. van Kessel. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. Journal of immunology (Baltimore, Md. : 1950) 172: 6994–7001.CrossRef
24.
go back to reference Haas, Pieter-Jan, Carla J.C. de Haas, Wendy Kleibeuker, Miriam J.J.G. Poppelier, Kok P.M. van Kessel, John A.W. Kruijtzer, Rob M.J. Liskamp, and Jos A.G. van Strijp. 2004. N-Terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. The Journal of Immunology 173. Haas, Pieter-Jan, Carla J.C. de Haas, Wendy Kleibeuker, Miriam J.J.G. Poppelier, Kok P.M. van Kessel, John A.W. Kruijtzer, Rob M.J. Liskamp, and Jos A.G. van Strijp. 2004. N-Terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. The Journal of Immunology 173.
27.
go back to reference Zhang, Q, M Raoof, Y Chen, Y Sumi, T Sursal, W Junger, K Brohi, K Itagaki, and C J Hauser. 2010. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464. Department of Surgery, Division of Trauma, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA: 104–107. Zhang, Q, M Raoof, Y Chen, Y Sumi, T Sursal, W Junger, K Brohi, K Itagaki, and C J Hauser. 2010. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464. Department of Surgery, Division of Trauma, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA: 104–107.
31.
go back to reference Hartl, D., S. Krauss-Etschmann, B. Koller, P.L. Hordijk, T.W. Kuijpers, F. Hoffmann, A. Hector, et al. 2008. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. The Journal of Immunology 181. American Association of Immunologists: 8053–8067. https://doi.org/10.4049/jimmunol.181.11.8053.CrossRefPubMed Hartl, D., S. Krauss-Etschmann, B. Koller, P.L. Hordijk, T.W. Kuijpers, F. Hoffmann, A. Hector, et al. 2008. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. The Journal of Immunology 181. American Association of Immunologists: 8053–8067. https://​doi.​org/​10.​4049/​jimmunol.​181.​11.​8053.CrossRefPubMed
32.
go back to reference Weathington, Nathaniel M., Anneke H. van Houwelingen, Brett D. Noerager, Patricia L. Jackson, Aletta D. Kraneveld, F. Shawn Galin, Gert Folkerts, Frans P. Nijkamp, and J. Edwin Blalock. 2006. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nature Medicine 12: 317–323. https://doi.org/10.1038/nm1361.CrossRefPubMed Weathington, Nathaniel M., Anneke H. van Houwelingen, Brett D. Noerager, Patricia L. Jackson, Aletta D. Kraneveld, F. Shawn Galin, Gert Folkerts, Frans P. Nijkamp, and J. Edwin Blalock. 2006. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nature Medicine 12: 317–323. https://​doi.​org/​10.​1038/​nm1361.CrossRefPubMed
37.
go back to reference Morgan, E.N., E.M. Boyle, W. Yun, J.C. Kovacich, T.G. Canty, E. Chi, T.H. Pohlman, and E.D. Verrier. 1999. Platelet-activating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury. Circulation 100: II365–II368.PubMed Morgan, E.N., E.M. Boyle, W. Yun, J.C. Kovacich, T.G. Canty, E. Chi, T.H. Pohlman, and E.D. Verrier. 1999. Platelet-activating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury. Circulation 100: II365–II368.PubMed
Metadata
Title
Serum from the Human Fracture Hematoma Contains a Potent Inducer of Neutrophil Chemotaxis
Authors
Okan W. Bastian
Mikolaj H. Mrozek
Marco Raaben
Luke P. H. Leenen
Leo Koenderman
Taco J. Blokhuis
Publication date
01-06-2018
Publisher
Springer US
Published in
Inflammation / Issue 3/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0760-4

Other articles of this Issue 3/2018

Inflammation 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.